A Study to Evaluate Leuprolide Acetate 45 mg 6-Month Formulation in Children With Central Precocious Puberty (CPP)

Clinical trial NCT03695237 · COMPLETED

Trial details

NCT number: NCT03695237
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Central Precocious Puberty (CPP)

Start date: 2018-10-24
Primary completion: 2021-05-06
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.